大肠杆菌
抗体
肠杆菌科
微生物学
医学
生物
免疫学
生物化学
基因
作者
Michael Covinsky,Omar Laterza,John D. Pfeifer,Tünde Farkas-Szallasi,Mitchell G. Scott
出处
期刊:Clinical Chemistry
[American Association for Clinical Chemistry]
日期:2000-08-01
卷期号:46 (8): 1157-1161
被引量:63
标识
DOI:10.1093/clinchem/46.8.1157
摘要
Abstract Background: Interferences in immunometric assays as a result of human anti-immunoglobulin antibodies frequently have been described in the literature. The etiology of these interfering antibodies is usually not known but has been associated with rheumatoid factors in some assays. It is known that microorganisms in experimental settings can induce anti-immunoglobulin antibodies. Methods: Following Escherichia coli septicemia, a 56-year-old male patient had increased immunoassay results for cardiac troponin I, thyrotropin, human chorionic gonadotropin, α-fetoprotein, and CA-125 that were consistent with myocardial infarction, hyperthyroidism, and pregnancy, and suggestive of an occult neoplasm such as hepatic or ovarian cancer. None of these diagnoses were consistent with the rest of his medical exam. In addition, the patient had a restricted IgM λ paraprotein by immunofixation. Plasma from the patient was incubated with Sepharose-conjugated protein A, irrelevant murine monoclonal antibodies, and formalin-killed E. coli organisms from his infection to determine whether these immunoassay values were falsely increased. Results: Incubation of the patient’s plasma with irrelevant murine monoclonal antibodies or the E. coli organism produced normal immunoassay values and removed the IgM λ paraprotein. Conclusions: The patient produced a very restricted IgM λ antibody response to the E. coli infection that had anti-immunoglobulin activity and caused falsely increased values in numerous immunometric assays. Microorganism-induced anti-immunoglobulin antibodies are discussed in the context of this patient.
科研通智能强力驱动
Strongly Powered by AbleSci AI